Post-COVID pulmonary fibrosis, which involves scarring of the lungs that can worsen over time and may require a lung ...
19h
The Brighterside of News on MSNPopular health supplement shows promise in reversing lung damageA recent study from the Women’s Guild Lung Institute at Cedars-Sinai suggests that zinc could help reverse lung damage in ...
6h
AZoLifeSciences on MSNCovid-19 lung researchChanges in the cellular response during lung damage caused by Covid-19 have been uncovered by a team of scientists.
Learn about idiopathic pulmonary fibrosis, its symptoms, diagnosis, and treatment options for managing this lung disease.
The global idiopathic pulmonary fibrosis market size was valued at USD 4.54 billion in 2024 and is projected to reach from ...
Progressive pulmonary fibrosis is not a diagnosis so much as a disease behavior and a clinical phenotype, says Anna-Maria ...
SINGAPORE: A new study from Duke-NUS Medical School has identified a promising new avenue for tackling pulmonary fibrosis, a ...
Marit's chronic, incurable lung disease has worsened, meaning she may have to change her schedule at short notice.
The following is a summary of "Supplemental oxygen therapy use among patients with fibrosing interstitial lung disease in the United States," published in the February 2025 issue of the Respiratory ...
The fundraiser is inspired, in part, by Michael Kuchwara, a famed Associated Press theater critic who died from pulmonary ...
Learn how new research and clinical trials at Memorial Sloan Kettering Cancer Center (MSK) have helped 32-year-old Giancarlo ...
Pliant Therapeutics has scrapped its Phase IIb Beacon-IPF trial for bexotegrast in idiopathic pulmonary fibrosis (IPF), after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results